Revel Pharmaceuticals
Company
Revel Pharmaceuticals develops one asset. Mostly protein or enzyme.
- 1
- Asset
- Furthest
- Not known
- Raised
- US$16m
- 2
- Grants
- 0
- Trials
- 0
- Signals
Pipeline
1Reverses protein glycation by removing accumulated glycation adducts.
Stage not known, Protein or enzyme
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Funding rounds and grants2
- People10
- Signals2
Updated 10 Oct 2026 · 5 sources